Correlation Between Neovacs SA and Novacyt

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Neovacs SA and Novacyt at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neovacs SA and Novacyt into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neovacs SA and Novacyt, you can compare the effects of market volatilities on Neovacs SA and Novacyt and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neovacs SA with a short position of Novacyt. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neovacs SA and Novacyt.

Diversification Opportunities for Neovacs SA and Novacyt

0.89
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Neovacs and Novacyt is 0.89. Overlapping area represents the amount of risk that can be diversified away by holding Neovacs SA and Novacyt in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Novacyt and Neovacs SA is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neovacs SA are associated (or correlated) with Novacyt. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Novacyt has no effect on the direction of Neovacs SA i.e., Neovacs SA and Novacyt go up and down completely randomly.

Pair Corralation between Neovacs SA and Novacyt

Assuming the 90 days trading horizon Neovacs SA is expected to generate 5.15 times more return on investment than Novacyt. However, Neovacs SA is 5.15 times more volatile than Novacyt. It trades about 0.03 of its potential returns per unit of risk. Novacyt is currently generating about -0.15 per unit of risk. If you would invest  0.03  in Neovacs SA on August 24, 2024 and sell it today you would lose (0.01) from holding Neovacs SA or give up 33.33% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy95.65%
ValuesDaily Returns

Neovacs SA  vs.  Novacyt

 Performance 
       Timeline  
Neovacs SA 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Neovacs SA has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in December 2024. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.
Novacyt 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Novacyt has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in December 2024. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Neovacs SA and Novacyt Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Neovacs SA and Novacyt

The main advantage of trading using opposite Neovacs SA and Novacyt positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neovacs SA position performs unexpectedly, Novacyt can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Novacyt will offset losses from the drop in Novacyt's long position.
The idea behind Neovacs SA and Novacyt pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.

Other Complementary Tools

Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Global Correlations
Find global opportunities by holding instruments from different markets
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios